Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris
Bazan, Silvia Boschi; Chaves, Agtha de Alencar Muniz; Aires, Karina Araújo; Cianciarullo, Aurora Marques; Garcea, Robert L.
Archives of Virology
; 154(10): 1609-1617, sept 10, 2009.
Artigo em Inglês | Sec. Est. Saúde SP, SESSP-IBPROD, Sec. Est. Saúde SP, SESSP-IBACERVO | ID: ses-21982
A Prize for Cancer Prevention.
Study of intact virus-like particles of human papillomavirus by capillary electrophoresis.
Characterization of Immunoglobulin A/G Responses During 3 Doses of the Human Papillomavirus-16/18 ASO4-Adjuvanted Vaccine.
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Impact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis.
A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.
[The role of the vaccine prophylaxis of cervical cancer among female military personnel].
Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women.
Reduced prevalence of vulvar HPV16/18 infection among women who received the HPV16/18 bivalent vaccine: a nested analysis within the Costa Rica Vaccine Trial.
Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization.